... after the company previously failed to list in the U.S. and Hong Kong, as well as an unsuccessful bit to achieve an A-share float via a reverse merger.
Growth Capitalist (https://growthcapitalist.com/2017/07/venture-backed-bgi-genomics-completes-250m-ipo-on-shenzhen-chinext/)
... after the company previously failed to list in the U.S. and Hong Kong, as well as an unsuccessful bit to achieve an A-share float via a reverse merger.